Literature DB >> 10814644

Multivessel coronary thrombosis, acute myocardial infarction, and no reflow in a patient with essential thrombocythaemia.

H Terada1, H Satoh, A Uehara.   

Abstract

Essential thrombocythaemia (ET) has been reported rarely to cause coronary thrombosis, but the management is still undefined. A 63 year old woman with multivessel coronary thrombosis, acute myocardial infarction (MI), and no reflow in reperfused coronary artery in association with ET is presented. The patient's platelet count was only moderately raised at the onset of MI, but peripheral blood smear and bone marrow evaluation revealed clumping giant platelets and numerous large hyperploid megakaryocytes. Long term prophylaxis with antiplatelet agents in patients with ET is recommended, even if the platelet count is not largely raised. Cytoreductive treatment may also be effective for secondary prevention when thrombotic complications occur.

Entities:  

Mesh:

Year:  2000        PMID: 10814644      PMCID: PMC1760868          DOI: 10.1136/heart.83.6.e10

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  Multiple, relapsing thrombosis in a young man with primary thrombocytosis.

Authors:  M L Randi; F Fabris; F Stocco; T Tison; A Girolami
Journal:  Blood Coagul Fibrinolysis       Date:  1990-08       Impact factor: 1.276

2.  Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine.

Authors:  M Ishihara; H Sato; H Tateishi; T Kawagoe; Y Shimatani; S Kurisu; K Sakai
Journal:  Am Heart J       Date:  1996-11       Impact factor: 4.749

3.  Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia.

Authors:  A D Michaels; B Whisenant; J S MacGregor
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

4.  Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.

Authors:  S Cortelazzo; G Finazzi; M Ruggeri; O Vestri; M Galli; F Rodeghiero; T Barbui
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

5.  Platelet counts in myocardial infarction, angina pectoris and peripheral artery disease.

Authors:  B Fagher; A Sjögren; U Sjögren
Journal:  Acta Med Scand       Date:  1985

6.  Acute coronary disease in essential thrombocythemia and polycythemia vera.

Authors:  C Rossi; M L Randi; P Zerbinati; V Rinaldi; A Girolami
Journal:  J Intern Med       Date:  1998-07       Impact factor: 8.989

7.  Coronary vasospasm, multiple coronary thrombosis, unstable angina and essential thrombocytosis.

Authors:  K K Koh; S K Cho; S S Kim; B H Oh; Y W Lee
Journal:  Int J Cardiol       Date:  1993-09       Impact factor: 4.164

8.  The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration.

Authors:  J F Martin; E A Trowbridge; G Salmon; J Plumb
Journal:  Thromb Res       Date:  1983-12-01       Impact factor: 3.944

9.  Thrombocytosis, coronary thrombosis and acute myocardial infarction.

Authors:  R Virmani; M A Popovsky; W C Roberts
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

10.  Myocardial infarction complicating postsplenectomy thrombocytosis, with early left ventricular mural thrombus formation and cerebral embolism--a case report.

Authors:  Y T Tai; Y L Yu; C P Lau; P C Fong
Journal:  Angiology       Date:  1993-01       Impact factor: 3.619

  10 in total
  4 in total

Review 1.  Multiple coronary thrombosis and stent implantation to the subtotally occluded right renal artery in a patient with essential thrombocytosis: a case report with review.

Authors:  Beste Ozben; Ahmet Ekmekci; Zehra Bugra; Sabahattin Umman; Mehmet Meric
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

2.  Essential thrombocythemia complicated with simultaneous two-vessel acute myocardial infarction in the subacute phase of takotsubo cardiomyopathy: A case report.

Authors:  Yusuke Yamazaki; Yohei Numasawa; Taro Mase; Takashi Maeda; Yuhei Shinoda; Kosuke Watabe; Shoya Ono; Ayami Naito; Souichi Yokokura; Sho Haginiwa; Hidenori Kojima; Makoto Tanaka
Journal:  J Cardiol Cases       Date:  2022-07-15

3.  Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report.

Authors:  Young-Hyo Lim; Young Yiul Lee; Jae Hoon Kim; Jinho Shin; Jae Ung Lee; Kyung-Soo Kim; Soon-Kil Kim; Jeong Hyun Kim; Heon Kil Lim
Journal:  Korean J Hematol       Date:  2010-06-30

4.  Challenges in the treatment of patients with essential thrombocythemia and acute coronary syndrome.

Authors:  Christina Doesch; Björn Krämer; Tobias Geisler; Andreas E May; Stefan-Martin Kroeber; Reinhard Kandolf; Meinrad Gawaz
Journal:  J Thromb Thrombolysis       Date:  2007-08-14       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.